↓ Skip to main content

Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism

Overview of attention for article published in this source, October 2004
Altmetric Badge

Mentioned by

wikipedia
1 Wikipedia page

Citations

dimensions_citation
240 Dimensions

Readers on

mendeley
53 Mendeley
connotea
2 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism
Published by
John Wiley & Sons, Ltd, October 2004
DOI 10.1002/14651858.cd001100.pub2
Pubmed ID
Authors

van Dongen, Carlo J, van den Belt, Angelique GM, Prins, Martin H, Lensing, AWA

Abstract

Low molecular weight heparins (LMWH) have been shown to be effective and safe in preventing venous thromboembolism (VTE), and may also be effective for the initial treatment of VTE.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 53 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 2%
United States 1 2%
France 1 2%
Unknown 50 94%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 15%
Researcher 7 13%
Student > Bachelor 6 11%
Student > Postgraduate 6 11%
Student > Doctoral Student 5 9%
Other 10 19%
Unknown 11 21%
Readers by discipline Count As %
Medicine and Dentistry 35 66%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Psychology 1 2%
Nursing and Health Professions 1 2%
Unknown 15 28%